950220 네오이뮨텍

기본 정보

• 섹터: KOSDAQ
• 시가총액: 441억원 (2026-06-30 기준)
• 첫 등장: 2026-06-10 (누적 2일)
• 태그: 매크로/바이오헬스 · 면역항암제 · T세포치료제 · IL-7 · 바이오
• 네이버 금융: 🔗

기업개요

• 동사는 2014년 설립된 T세포 기반 면역치료제 연구개발 생명공학 기업으로, 2021년 코스닥에 상장했음.
• 장기 지속형 IL-7 계열 T세포 증폭제 NT-I7을 핵심으로, Heterodimer Fc 플랫폼 기반 차세대 면역항암 파이프라인을 개발 중임.
• 희귀질환 치료제 엔다리의 북미 독점 라이선스를 확보해 상업화 제품 매출과 혁신 면역치료제 개발을 병행하는 이원적 사업 구조를 구축하고 있음.

출처: 네이버증권 종목분석 (WiseReport)

일자별 등장 (최신 위, 누적)

일자	전일 종가	종가	등락률	시간외	vol	색깔	smart	외	연	금투	투	개	그외
2026-08-14	1,551	1,621	🔴 +4.51%	—	×0.7	🟢 외인	+0.3억	+0.3	+0.0	+0.0	+0.0	-0.3	-0.1
2026-08-13	1,577	1,551	🔵 -1.65%	—	×0.4	🔻 개인	-0.2억	-0.2	+0.0	+0.0	+0.0	+0.2	+0.0
2026-08-12	1,546	1,577	🔴 +2.01%	—	×0.6	🔻 개인	-0.1억	-0.1	+0.0	+0.0	+0.0	+0.1	+0.0
2026-08-11	1,524	1,546	🔴 +1.44%	—	×0.5	🔻 개인	-0.2억	-0.2	+0.0	+0.0	+0.0	+0.1	+0.1
2026-08-10	1,529	1,524	🔵 -0.33%	—	×0.7	🟢 외인	+0.3억	+0.3	+0.0	+0.0	+0.0	-0.3	-0.0
2026-08-07	1,365	1,529	🔴 +12.01%	—	×21.6	🔻 개인	-1.2억	-1.2	+0.0	+0.0	+0.0	+1.2	+0.0
2026-08-06	1,373	1,365	🔵 -0.58%	—	×0.8	🟢 외인	+0.3억	+0.3	+0.0	+0.0	+0.0	-0.2	-0.1
2026-08-05	1,379	1,373	🔵 -0.44%	—	×1.8	🟢 외인	+0.3억	+0.3	+0.0	+0.0	+0.0	-0.3	+0.1
2026-08-04	1,328	1,379	🔴 +3.84%	—	×1.2	🟢 외인	+0.6억	+0.6	+0.0	+0.0	+0.0	-0.6	+0.0
2026-08-03	1,305	1,328	🔴 +1.76%	—	×1.1	🟢 외인	+0.6억	+0.6	+0.0	+0.0	+0.0	-0.6	+0.0
2026-07-31	1,193	1,305	🔴 +9.39%	—	×1.4	🟢 외인	+0.5억	+0.5	+0.0	+0.0	+0.0	-0.5	+0.0
2026-07-30	1,217	1,193	🔵 -1.97%	—	×0.6	🔻 개인	+0.0억	+0.0	+0.0	+0.0	+0.0	+0.0	+0.0
2026-07-29	1,318	1,217	🔵 -7.66%	—	×1.7	🔻 개인	-0.3억	-0.3	+0.0	+0.0	+0.0	+0.3	-0.1
2026-07-28	1,360	1,318	🔵 -3.09%	—	×0.6	🟢 외인	+0.0억	+0.0	+0.0	+0.0	+0.0	-0.0	+0.0
2026-07-27	1,301	1,360	🔴 +4.53%	—	×0.7	🟢 외인	+0.0억	+0.0	+0.0	+0.0	+0.0	-0.0	+0.0
2026-07-24	1,293	1,301	🔴 +0.62%	—	×0.9	⚫ 그외	+0.3억	+0.3	+0.0	-0.0	+0.0	-0.8	+0.6
2026-07-23	1,280	1,293	🔴 +1.02%	—	×0.7	🟢 외인	+0.2억	+0.2	+0.0	+0.0	+0.0	-0.2	+0.0
2026-07-22	1,317	1,280	🔵 -2.81%	—	×1.1	🟢 외인	+0.5억	+0.5	+0.0	+0.0	+0.0	-0.5	+0.0
2026-07-21	1,300	1,317	🔴 +1.31%	—	×0.4	🔻 개인	-0.2억	-0.2	+0.0	+0.0	+0.0	+0.2	+0.0
2026-07-20	1,364	1,300	🔵 -4.69%	—	×0.5	🔻 개인	-0.3억	-0.3	+0.0	+0.0	+0.0	+0.3	+0.0
2026-07-10	1,288	1,342	🔴 +4.19%	—	×0.2	🟢 외인	+0.5억	+0.5	+0.0	+0.0	-0.5	+0.0
2026-07-09	1,260	1,288	🔴 +2.22%	—	×0.4	⚫ 그외	+0.2억	+0.2	+0.0	+0.0	-0.6	+0.4
2026-07-08	1,320	1,260	🔵 -4.55%	—	×0.5	🔻 개인	-0.5억	-0.5	+0.0	+0.0	+0.5	+0.0
2026-07-07	1,361	1,320	🔵 -3.01%	—	×0.3	⚫ 그외	+0.0억	+0.0	+0.0	+0.0	-0.1	+0.1
2026-07-06	1,327	1,361	🔴 +2.56%	—	×0.2	⚫ 그외	+0.3억	+0.3	+0.0	+0.0	-0.7	+0.3
2026-07-03	1,279	1,327	🔴 +3.75%	—	×0.4	🟢 외인	+0.0억	+0.0	+0.0	-0.0	-0.0	-0.0
2026-07-02	1,361	1,279	🔵 -6.02%	—	×0.4	🟢 외인	+0.4억	+0.4	+0.0	+0.0	-0.4	+0.0
2026-07-01	1,316	1,361	🔴 +3.42%	—	×0.2	🟢 외인	+0.1억	+0.1	+0.0	+0.0	-0.1	+0.0
2026-06-30	1,323	1,316	🔵 -0.53%	—	×0.4	🔻 개인	-0.5억	-0.5	+0.0	+0.0	+0.4	+0.0
2026-06-29	1,260	1,323	🔴 +5.00%	—	×0.2	🟢 외인	+0.4억	+0.4	+0.0	+0.0	-0.4	+0.0
2026-06-26	1,320	1,260	🔵 -4.55%	—	×0.3	🟢 외인	+0.8억	+0.8	+0.0	+0.0	-0.8	+0.0
2026-06-25	1,390	1,320	🔵 -5.04%	—	×0.2	🔻 개인	-0.2억	-0.2	+0.0	+0.0	+0.2	-0.0
2026-06-24	1,342	1,390	🔴 +3.58%	—	×0.2	🟢 외인	+0.3억	+0.3	+0.0	+0.0	-0.2	-0.0
2026-06-23	1,435	1,342	🔵 -6.48%	—	×0.4	🟢 외인	+0.1억	+0.1	+0.0	+0.0	-0.1	+0.1
2026-06-22	1,566	1,435	🔵 -8.37%	—	×0.3	⚫ 그외	-0.1억	-0.1	+0.0	+0.0	-0.2	+0.4
2026-06-19	1,650	1,566	🔵 -5.09%	—	×0.2	⚫ 그외	-0.3억	-0.3	+0.0	+0.0	-0.6	+0.9
2026-06-18	1,700	1,650	🔵 -2.94%	—	×0.5	⚫ 그외	+0.5억	+0.5	+0.0	+0.0	-2.3	+1.8
2026-06-17	1,465	1,700	🔴 +16.04%	—	×3.6	⚫ 그외	-0.2억	-0.2	+0.0	+0.0	-1.2	+1.4
2026-06-16	1,542	1,465	🔵 -4.99%	—	×0.6	🔻 개인	+0.0억	+0.0	+0.0	+0.0	+0.2	-0.2
2026-06-15	1,604	1,542	🔵 -3.87%	—	×0.4	⚫ 그외	+0.1억	+0.1	+0.0	+0.0	-0.2	+0.1
2026-06-12	1,600	1,604	🔴 +0.25%	—	×0.3	🟢 외인	+0.2억	+0.2	+0.0	+0.0	-0.2	+0.0
2026-06-11	1,767	1,600	🔵 -9.45%	—	×0.3	🟢 외인	+0.5억	+0.5	+0.0	+0.0	-0.4	-0.1
2026-06-10	501	1,767	🔴 +252.69%	—	—	🔻 개인	-1.2억	-1.2	+0.0	-0.8	+2.6	-0.6
2026-06-09	501	501	⚪ +0.00%	—	—	🔻 개인	+0.0억	+0.0	+0.0	+0.0	+0.0	+0.0
2026-06-08	501	501	⚪ +0.00%	—	—	🔻 개인	+0.0억	+0.0	+0.0	+0.0	+0.0	+0.0
2026-06-05	501	501	⚪ +0.00%	—	—	🔻 개인	+0.0억	+0.0	+0.0	+0.0	+0.0	+0.0
2026-06-04	501	501	⚪ +0.00%	—	—	🔻 개인	+0.0억	+0.0	+0.0	+0.0	+0.0	+0.0
2026-06-02	501	501	⚪ +0.00%	—	—	🔻 개인	+0.0억	+0.0	+0.0	+0.0	+0.0	+0.0
2026-06-01	501	501	⚪ +0.00%	—	—	🔻 개인	+0.0억	+0.0	+0.0	+0.0	+0.0	+0.0
2026-05-29	501	501	⚪ +0.00%	—	—	🔻 개인	+0.0억	+0.0	+0.0	+0.0	+0.0	+0.0
2026-05-28	501	501	⚪ +0.00%	—	—	🔻 개인	+0.0억	+0.0	+0.0	+0.0	+0.0	+0.0
2026-05-27	501	501	⚪ +0.00%	—	—	🔻 개인	+0.0억	+0.0	+0.0	+0.0	+0.0	+0.0
2026-05-26	501	501	⚪ +0.00%	—	—	🔻 개인	+0.0억	+0.0	+0.0	+0.0	+0.0	+0.0
2026-05-22	501	501	⚪ +0.00%	—	—	🔻 개인	+0.0억	+0.0	+0.0	+0.0	+0.0	+0.0

일자별 사유 (최신 위)

2026-08-07

• 사유: —
• 섹터 컨텍스트: 기타 (smart +0.0억)
• 매크로 원인: 바이오헬스 개별 이슈 겹침: 랩지노믹스 미국 암진단 라이선스 계약, 대화제약 배당·실적 공시 (보통)

2026-06-17

• 사유: 동전주 탈출·바이오 반등 수급 유입
• 섹터 컨텍스트: 기타 (smart +0.0억)
• 매크로 원인: 바이오 USA 개막발 기술이전 기대 + FDA·임상 호재로 소외됐던 제약바이오 일제 반등 (보통)

2026-06-10

• 사유: 엔다리 판권대금 지분전환+15억 3자배정 유증 결정
• 섹터 컨텍스트: 기타 (smart +0.0억)
• 매크로 원인: 공통 매크로 테마 없이 개별 종목 재료(줄기세포 전임상·유증 결정)로 각자 급등 (보통)